U-Blot® Research Grade MOR102Cat. No. WA3184$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade MOR102Cat. No. WA3184
U-Blot® Research Grade MOR101Cat. No. WA3183
U-Blot® Research Grade moponetugCat. No. WA3182
U-Blot® Research Grade MonalizumabCat. No. WA3181
U-Blot® Research Grade MogamulizumabCat. No. WA3180
U-Blot® Research Grade moflerafusp alfaCat. No. WA3179
U-Blot® Research Grade ModotuximabCat. No. WA3178
U-Blot® Research Grade Modakafusp alfaCat. No. WA3177
U-Blot® Research Grade mocertatugCat. No. WA3176
U-Blot® Research Grade MK-4830Cat. No. WA3175
U-Blot® Research Grade MK-4721Cat. No. WA3174
U-Blot® Research Grade MK-4721Cat. No. WA3173